Early clinical experience with cimetidine in duodenal ulcer patients.

作者: J. F. Groarke , O. FitzGerald

DOI: 10.1007/BF02938940

关键词:

摘要: Nineteen patients with duodenal ulcer have been treated cimetidine 1.2 G daily for six weeks. All experienced striking symptomatic improvement. Measurement of gastric secretion showed that tolerance to had not developed after weeks treatment. No significant side effects were noted. Cimetidine appears be a safe and effective means controlling symptoms. Controlled trials are indicated.

参考文章(18)
W.L. Burland, Treatment of duodenal ulcer by metiamide The Lancet. ,vol. 306, pp. 779- 781 ,(1975) , 10.1016/S0140-6736(75)80001-8
M.H. Thompson, C.W. Venables, I.T. Miller, J.D. Reed, D.J. Sanders, E.R. Grund, E.L. Blair, METIAMIDE IN ZOLLINGER-ELLISON SYNDROME The Lancet. ,vol. 305, pp. 35- 36 ,(1975) , 10.1016/S0140-6736(75)92392-2
M. H. Thompson, J. D. Reed, G. Dale, C. W. Venables, Early clinical experience with metiamide, a histamine H2-receptor antagonist, in patients with duodenal ulcer. Digestive Diseases and Sciences. ,vol. 20, pp. 1135- 1141 ,(1975) , 10.1007/BF01070757
B. Thjodleifsson, K. G. Wormsley, Gastric Response to Metiamide BMJ. ,vol. 2, pp. 304- 306 ,(1974) , 10.1136/BMJ.2.5914.304
WL Burland, WA Duncan, T Hesselbo, JG Mills, PC Sharpe, SJ Haggie, JH Wyllie, Pharmacological evaluation of cimetidine, a new histamine H2-receptor antagonist, in healthy man. British Journal of Clinical Pharmacology. ,vol. 2, pp. 481- 486 ,(1975) , 10.1111/J.1365-2125.1975.TB00564.X
Stanis?aw J. Konturek, Jerzy Biernat, Jan Oleksy, Effect of metiamide, a histamine H2-receptor antagonist, on gastric response to histamine, pentagastrin, insulin, and peptone meal in man The American Journal of Digestive Diseases. ,vol. 19, pp. 609- 616 ,(1974) , 10.1007/BF01073015
J.A.H. Forrest, D.J.C. Shearman, R. Spence, L.R. Celestin, NEUTROPENIA ASSOCIATED WITH METIAMIDE The Lancet. ,vol. 305, pp. 392- 393 ,(1975) , 10.1016/S0140-6736(75)91305-7